MedWatch

GN Hearing expands flagship portfolio with new product

Hearing aid manufacturer GN Hearing is launching a new device in the Resound One family, and according to CEO Gitte Aabo, it is the first sign of the company getting back on track after last October’s R&D letdowns, which led to a new head of the division and a significant downgrade.

Gitte Aabo, CEO of GN Hearing | Photo: GN Store Nord / PR

Work behind the scenes at Demant has been in full swing since last October, which brought a significant financial downgrade that also left the hearing aid manufacturer’s head of research and development without a job.

Today, the result is a new launch of a hearing aid in the Resound One family, which is GN Hearing’s flagship portfolio: a behind-the-ear (BTE) device with hands-free Facetime and calling functions. Up to now, the portfolio was comprised of receiver-in-ear (RIE) hearing aids.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Britt Meelby Jensen wants to rebuild trust in Ambu

After a turbulent time for Ambu under Juan Jose Gonzalez’s reign, new chief executive appointee Britt Meelby Jensen aims to rebuild the trust in the medtech firm, which has downgraded its expectations seven times over the past three years.

Outgoing Ambu CEO commends colleagues

”A true privilege,” says Juan Jose Gonzalez, describing his time as CEO at Ambu, which came to an end with Thursday’s announcement that Britt Meelby Jensen would take over the role.

Further reading

Related articles

Latest news

See all jobs